Research analysts at StockNews.com started coverage on shares of SenesTech (NASDAQ:SNES – Get Free Report) in a report released on Thursday. The firm set a “sell” rating on the stock.
Separately, HC Wainwright reissued a “buy” rating and issued a $3.50 price target on shares of SenesTech in a report on Tuesday, May 14th.
Read Our Latest Research Report on SenesTech
SenesTech Price Performance
SenesTech (NASDAQ:SNES – Get Free Report) last announced its quarterly earnings results on Thursday, May 9th. The company reported ($0.36) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.34) by ($0.02). SenesTech had a negative return on equity of 181.46% and a negative net margin of 545.82%. The company had revenue of $0.42 million for the quarter, compared to the consensus estimate of $0.43 million. During the same quarter last year, the company posted ($15.85) EPS. As a group, analysts anticipate that SenesTech will post -1.1 earnings per share for the current fiscal year.
Hedge Funds Weigh In On SenesTech
A hedge fund recently bought a new stake in SenesTech stock. McAdam LLC bought a new stake in SenesTech, Inc. (NASDAQ:SNES – Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 64,348 shares of the company’s stock, valued at approximately $44,000. McAdam LLC owned about 1.25% of SenesTech as of its most recent SEC filing. 5.19% of the stock is owned by institutional investors.
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Read More
- Five stocks we like better than SenesTech
- Are Penny Stocks a Good Fit for Your Portfolio?
- AbbVie Stock: A Perfect Dip for Investors to Buy
- Best Stocks Under $10.00
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
- With Risk Tolerance, One Size Does Not Fit All
- GitLab Stock Rebounds: The Inside Story of Its Comeback
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.